Tirzepatide found to be more cost-effective than semaglutide in patients with knee osteoarthritis, obesity
A microsimulation model was used to evaluate the cost-effectiveness of two glucagon-like peptide-1 receptor agonists (GLP1RAs), semaglutide and tirzepatide, for patients with osteoarthritis and obesity compared with usual ...
51 minutes ago
0
0